The DOI matches its Crossref record; 105 of the 108 references it cites were found in a registry or an index.
Oxidative stress markers in affective disorders
Open accessAbstract
Affective disorders are a medical condition with a complex biological pattern of etiology, involving genetic and epigenetic factors, along with different environmental stressors. Increasing numbers of studies indicate that induction of oxidative and nitrosative stress (O&NS) pathways, which is accompanied by immune-inflammatory response, might play an important role in the pathogenic mechanisms underlying many major psychiatric disorders, including depression and bipolar disorder. Reactive oxygen and nitrogen species have been shown to impair the brain function by modulating activity of principal neurotransmitter (e.g., glutamatergic) systems involved in the neurobiology of depression. Both preclinical and clinical studies revealed that depression is associated with altered levels of oxidative stress markers and typically reduced concentrations of several endogenous antioxidant compounds, such as glutathione, vitamin E, zinc and coenzyme Q10, or enzymes, including glutathione peroxidase, and with an impairment of the total antioxidant status. These oxidative stress parameters can be normalized by successful antidepressant therapy. On the other hand, some antioxidants (zinc, N-acetylcysteine, omega-3 free fatty acids) may exhibit antidepressant properties or enhance standard antidepressant therapy. These observations introduce new potential targets for the development of therapeutic interventions based on antioxidant compounds. The present paper reviews selected animal and human studies providing evidence that oxidative stress is implicated in the pathophysiology and treatment of depression and bipolar disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As mentioned earlier, patients with mood disorders have decreased antioxidant capacity and oxidative stress damage62.”
From Optimizing multi-domain hematologic biomarkers and clinical features for the differential diagnosis of unipolar depression and bipolar depression (2023) · cites this paper as [62]
In the citing paper
“Pavón et al. found elevated IL-13 serum levels in MDD patients.”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [14]
In the citing paper
“GABA has been found to be lowered in the plasma and cerebrospinal fluid in patients with depression (Siwek et al. 2013).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Siwek et al. 2013
In the citing paper
“Quantitative analysis confirmed that increased levels of thiobarbituric acid reactive substances (TBARS), formed as a byproduct of lipid peroxidation have been shown to be elevated.”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Siwek et al. 2013
In the citing paper
“In addition, elevated levels of malondialdehyde (MDA), 4-hydroxynonenal (HNE), and 8-iso-PGF2α have been found in the prefrontal cortex (de Souza et al. 2014; Siwek et al. 2013).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Siwek et al. 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Rio, D. D., Stewart, A. J., & Pellegrini, N. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.05.003 · Cited by 2,789
Janero, D. R. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90131-2 · Cited by 2,735
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
Protein carbonyl groups as biomarkers of oxidative stress
Dalle‐Donne, I., Rossi, R., Giustarini, D., Milzani, A., & Colombo, R. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00003-2 · Cited by 2,352
Biochemistry of oxidative stress
Halliwell, B. B. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351147 · Cited by 1,591
Oxidative stress: From basic research to clinical application
Sies, H. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90281-2 · Cited by 1,365
Biochemistry of Oxidative Stress
Sies, H. (1986) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198610581 · Cited by 1,316
Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140
Cited by
Sorted by citations
Items 101–142 of 142
Birģele, Z., Vimba, P. M., Ševčenko, A., Šķesters, A., Ancāne, G., & Valaine, L. (2024) · Medicina · doi:10.3390/medicina61010003 · Cited by 5
Paraoxonase (PON1) L55M and Q192R polymorphisms in major depression and bipolar affective disorder
Yıldız, M., Çelıkel, F. Ç., Ateş, Ö., Taycan, S. E., Benli, İ., & Demir, O. (2017) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/0101-60830000000123 · Cited by 5
High Catalase and Low Thiol Levels in Adult-ADHD Patients
Alpak, G., Selek, S., Bulut, M., Bülbül, F., Ünal, A., Vırıt, O., Kılıç, O. H. T., Gergerlioğlu, H. S., & SAVAS, H. A. (2014) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20140429091127 · Cited by 5
Papke, V., Klimes‐Dougan, B., Sahasrabudhe, S. A., Mueller, B. A., Park, Y. W., Öz, G., Eberly, L. E., DiMaggio-Potter, M. E., Kartha, R. V., Cloyd, J. C., et al. (2025) · BJPsych Open · doi:10.1192/bjo.2025.10839 · Cited by 4
New Light on Prions: Putative Role of PrPc in Pathophysiology of Mood Disorders
Chrobak, A. A., Pańczyszyn-Trzewik, P., Król, P., Pawelec-Bąk, M., Dudek, D., & Siwek, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052967 · Cited by 6
Self-citationOlive fruit and olive oil bioactive polyphenols in the promotion of health
Ray, N. B., Hilsabeck, K. D., Pitsillou, E., Mann, A., Karagiannis, T. C., & McCord, D. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819815-5.00014-8 · Cited by 4
Maciejska, A., Skórkowska, A., Jurczyk, J., Pomierny, B., & Budziszewska, B. (2023) · Biomarkers in disease · doi:10.1007/978-3-031-07392-2_17 · Cited by 4
Tocco, M., Newcomer, J. W., Mao, Y., & Pikalov, A. (2023) · CNS Spectrums · doi:10.1017/s1092852923001190 · Cited by 5
Xiong, S., Liao, L., Chen, M., & Gan, Q. Y. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1564380 · Cited by 3
Cechnicki, A., Chrobak, A. A., Plencler, I., Stankiewicz, P., Kalisz, A., Błądziński, P., Kruk, D., Radoń, S., Szewczyk, B., Faron‐Górecka, A., et al. (2025) · Annals of General Psychiatry · doi:10.1186/s12991-025-00587-5 · Cited by 3
Self-citationSamaryn, E., Galińska-Skok, B., Nobis, A., Zalewski, D., Maciejczyk, M., Gudowska-Sawczuk, M., Mroczko, B., Zalewska, A., & Waszkiewicz, N. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12227049 · Cited by 3
Vegetarian Diet and Possible Mechanisms for Impact on Mood
Johnston, C. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803968-7.00028-9 · Cited by 4
Zinc, copper, and magnesium in premenstrual disorders: a narrative review
Krupa, A. J., Zybała-Pawłowska, M., Kania, M., Turek, J., Szewczyk, B., Grabrucker, A. M., & Siwek, M. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00791-w · Cited by 4
Self-citationMaciejska, A., Skórkowska, A., Jurczyk, J., Pomierny, B., & Budziszewska, B. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-87225-0_17-1 · Cited by 2
Gholipour, D., Shahraki, M., Saravani, M., Payandeh, A., & Eslahi, H. (2024) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2022.4292.1 · Cited by 2
Bipolar bozuklukta allostaz ve allostatik yükü yeniden değerlendirmek
Özerdem, A. (2015) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.5350/dajpn20152803001 · Cited by 2
Stroot, P. G. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.11.009 · Cited by 2
Paraoxonase (PON1) L55M and Q192R polymorphisms in major depression and bipolar affective disorder
Yıldız, M., Çelıkel, F. Ç., Ateş, Ö., Taycan, S. E., Benli, İ., & Demir, O. (2017) · Journal of Mood Disorders · doi:10.5455/jmood.20170304070525 · Cited by 2
Determination of oxidative stress parameters in fluoxetine users
Perassolo, M. S., Raasch, J. R., Vargas, T. G., dos Santos, A. S., Silva, N. A., Hahn, R. Z., Ziulkoski, A. L., Linden, R., & Betti, A. H. (2020) · International Journal for Innovation Education and Research · doi:10.31686/ijier.vol8.iss5.2328 · Cited by 2
Rebouças, M. D. O., da Silva, D. M. A., Vale, L. D. C., Valentim, J. T., de Oliveira, N. F., de Carvalho, A. M. R., de Oliveira, A. A., Chaves, R. D. C., Luciano, M. C. D. S., & de Sousa, F. C. F. (2024) · Archives of Psychiatry and Psychotherapy · doi:10.12740/app/175726 · Cited by 1
Křenek, P., Bartečková, E., Makarová, M., Pompa, T., Kučerová, J., Kučera, J., Damborská, A., Hořínková, J., & Vašků, J. B. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1425552 · Cited by 2
Hsu, C., Huang, T. L., & Tsai, M.-C. (2016) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000169 · Cited by 1
Redox impairment in affective disorders and therapeutic potential of phenolic bioactive compounds
Bertollo, A. G., da Silva, G. B., da Cunha, I. C. E., Bagatini, M. D., & Ignácio, Z. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00006-3 · Cited by 1
Панарина, О. (2018) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2018-3.3.13 · Cited by 1
Effect of diallyl disulfide on lipopolysaccharide-induced depression-like behavior in micePreprint
Lu, J., He, H., Huang, C. I., & Chen, Z. (2019) · doi:10.21203/rs.2.19757/v1 · Cited by 1
Exploración de un modelo de estadiaje clínico aplicado al trastorno bipolar
Tatay, A. (2015) · Dialnet (Universidad de la Rioja)
Exposure to Toxic Chemicals as a Cause of Depression
Shaw, W. (2015) · CRC Press eBooks · doi:10.1201/b19089-15
Newton, D. F. (2015) · TSpace (University of Toronto)
Sowa-Kućma, M., Pańczyszyn-Trzewik, P., Misztak, P., & Nowak, G. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.11.520
Self-citationMeyer, B. J. (2018) · MDPI eBooks · doi:10.3390/books978-3-03842-972-2
Panwar, R., & Rajasekhar.S.S.S., N. (2022) · Scholars Journal of Medical Case Reports · doi:10.36347/sjmcr.2022.v10i04.030
Novel therapeutic approaches targeting oxidative stress in mood disorders
Bambokian, A., Gomes, F. A., Sjaarda, C. P., Soares, C. N., Milev, R. V., & Brietzke, E. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90905-1.00001-8
Gao, B., Qu, Y., Zhang, Y., Lu, H., Li, H., Tang, Y., & Hui, S. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4117036
Ali, M. (2020) · Annals of the Academy of Romanian Scientists Series on Biological Sciences · doi:10.56082/annalsarscibio.2020.2.50
Wei, Z., & Zhong, C. (2023) · Research Square · doi:10.21203/rs.3.rs-2791522/v1
Hussein, R. A., Ali, I. N., & Sayer, S. A. (2023) · Academia Open · doi:10.21070/acopen.8.2023.7830
Dissociative Identity Disorder Cotreated With Zinc and L-carnosine: A Case Report
Sakae, K., Suka, M., & Yanagisawa, H. (2024) · Cureus · doi:10.7759/cureus.74794
Brinholi, F. F., Vasupanrajit, A., Semeão, L. D. O., Michelin, A. P., Matsumoto, A. K., Almulla, A. F., Tunvirachaisakul, C., Barbosa, D. S., & Maes, M. H. J. (2024) · medRxiv · doi:10.1101/2024.03.13.24304226
Major Depression and Metabolic Syndrome
Marazziti, D., Cappellato, G., Chiarantini, I., Palermo, S., Arone, A., & Dell’Osso, L. (2026) · Springer eBooks · doi:10.1007/978-3-031-96019-2_3
Викторовна, М. Е., Levchuk, L. A., Boiko, A. S., Vyalova, N. M., Epimakhova, E. V., Paderina, D. Z., Roschina, O. V., Simutkin, G. G., Bokhan, N. A., & Ivanova, S. A. (2026) · Biochemistry (Moscow) · doi:10.1134/s0006297926600304
Zhao, L., Yang, Y., Cai, B., Wu, K., Gong, Y., Chen, Q., Li, X., & Luo, J. (2026) · ALPHA PSYCHIATRY · doi:10.31083/ap49803
Odeh, O. C., Okpakpor, E. E., Frank, S. G., Bolanle, I. O., & Ozolua, R. I. (2026) · Applied Biosciences · doi:10.3390/applbiosci5030074
Metadata
- Authors
- Siwek, M., Sowa-Kućma, M., Dudek, D., Styczeń, K., Szewczyk, B., Kotarska, K., Misztak, P., Pilc, A., Wolak, M., & Nowak, G.
- Affiliations
- Jagiellonian University (PL)
- Maj Institute of Pharmacology (PL)
- Corresponding author
- Siwek, Marcin
- Sowa-Kućma, Magdalena
- ORCID
- Venue
- Pharmacological Reports
- Published
- 2013-11
- Volume
- 65
- Issue
- 6
- Pages
- 1558-1571
- ISSN
- 1734-1140 (ISSN-L)
- OpenAlex
- W2040817682
- Cited by
- 142
- References
- 108
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 17 · 2023: 14 · 2022: 12 · 2021: 12 · 2020: 7 · 2019: 7 · 2018: 8 · 2017: 13 · 2016: 14 · 2015: 19 · 2014: 6 · 2013: 2
- FWCI
- 0.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Pharmacological Reports (publishedVersion)
- PubMed (publishedVersion)
- Jagiellonian University Repository (Jagiellonian University) (submittedVersion, cc-by-nc-nd)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- oxidative stress, nitrosative stress, mood disorders, depression, bipolar disorder, antioxidant biomarkers, glutathione, vitamin E, zinc, coenzyme Q10, glutathione peroxidase, total antioxidant status, reactive oxygen species, reactive nitrogen species, glutamatergic system, immune-inflammatory response, antidepressant treatment, N-acetylcysteine, omega-3 fatty acids, antioxidant therapy
- MeSH terms
- Animals, Antidepressive Agents, Humans, Biomarkers, Oxidative Stress, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
